Re-defining the unique roles for eosinophils in allergic respiratory inflammation - PubMed
Review
Re-defining the unique roles for eosinophils in allergic respiratory inflammation
E A Jacobsen et al. Clin Exp Allergy. 2014 Sep.
Abstract
The role of eosinophils in the progression and resolution of allergic respiratory inflammation is poorly defined despite the commonality of their presence and in some cases their use as a biomarker for disease severity and/or symptom control. However, this ambiguity belies the wealth of insights that have recently been gained through the use of eosinophil-deficient/attenuated strains of mice that have demonstrated novel immunoregulatory and remodelling/repair functions for these cells in the lung following allergen provocation. Specifically, studies of eosinophil-deficient mice suggest that eosinophils contribute to events occurring in the lungs following allergen provocation at several key moments: (i) the initiating phase of events leading to Th2-polarized pulmonary inflammation, (ii) the suppression Th1/Th17 pathways in lung-draining lymph nodes, (iii) the recruitment of effector Th2 T cells to the lung, and finally, (iv) mechanisms of inflammatory resolution that re-establish pulmonary homoeostasis. These suggested functions have recently been confirmed and expanded upon using allergen provocation of an inducible eosinophil-deficient strain of mice (iPHIL) that demonstrated an eosinophil-dependent mechanism(s) leading to Th2 dominated immune responses in the presence of eosinophils in contrast to neutrophilic as well as mixed Th1/Th17/Th2 variant phenotypes in the absence of eosinophils. These findings highlighted that eosinophils are not exclusively downstream mediators controlled by T cells, dendritic cells (DC) and/or innate lymphocytic cells (ILC2). Instead, eosinophils appear to be more aptly described as significant contributors in complex interrelated pathways that lead to pulmonary inflammation and subsequently promote resolution and the re-establishment of homoeostatic baseline. In this review, we summarize and put into the context the evolving hypotheses that are now expanding our understanding of the roles eosinophils likely have in the lung following allergen provocation.
© 2014 John Wiley & Sons Ltd.
Conflict of interest statement
Conflict of interest
The authors have no conflict of interest to declare.
Figures
![Figure 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9915/4148640/6756f856c95c/nihms605360f1.gif)
Through the use of eosinophil-deficient/attenuated strains of mice and adoptive transfer techniques in models of allergic respiratory inflammation various effector functions of eosinophils have been identified. These effector functions include role(s) in (1) Initiation, (2) Polarization/Proliferation, (3) Recruitment of Th2 cells/Th2 propagation, and (4) Resolution of the inflammatory events. (1) Initiation. Stromal cells and resident leukocytes respond to airway allergens by producing cytokines, chemokines, and other mediators that aid in the recruitment and activation of eosinophils to the lung. Eotaxin-1 (CCL11) and eotaxin-2(CCL24) by epithelial cells, macrophage, and endothelial cells recruit eosinophils to the lung from the periphery. L-33 and GM-CSF aid in activation and survival of eosinophils once in the lung. Eosinophils enhance their survival via autocrine and paracrine release of mediators (e.g., IL-5 and GM-CSF). Eosinophils enhance the activities of other cells through release of mediators (e.g., cytokine, reactive oxygen species, leukotrienes, lipids, and granule proteins). (2) Polarization/Proliferation. Once eosinophils are primed in the lung they migrate to the lung draining lymph node (LDLN) to aid in the secondary immune response. In particular, eosinophils are necessary for antigen-specific T cell proliferation in an MHC II-independent manner in the LDLN through inducing accumulation of DCs. Eosinophils suppress Th1/Th17 polarization and enhance Th2 polarization through release of mediators that are undefined, but may include IDO, TGF-β, and IL-10. (3) Recruitment of Th2 cells/Th2 Propagation. Eosinophils are necessary to induce recruitment of effector Th2 T cells through the production of TARC and MDC. Eosinophils enhance accumulation and activation of DCs. Eosinophils aid in the propagation of inflammatory responses through production of IL-4 and IL-13, as well as other mediators (e.g., cytokine, reactive oxygen species, leukotrienes, lipids, and granule proteins). (4) Resolution. Eosinophils may contribute to the resolution process by polarization of macrophage to M2 (via IL-4/13) and through release of protectins and resolvins (12/15-lipoxygenase products). Failure to polarize toward Th2 and to resolve inflammation may predispose the inflammation toward a neutrophilic/Th1/Th17 phenotype.
Similar articles
-
Jacobsen EA, Lesuer WE, Willetts L, Zellner KR, Mazzolini K, Antonios N, Beck B, Protheroe C, Ochkur SI, Colbert D, Lacy P, Moqbel R, Appleton J, Lee NA, Lee JJ. Jacobsen EA, et al. Allergy. 2014 Mar;69(3):315-27. doi: 10.1111/all.12321. Epub 2013 Nov 25. Allergy. 2014. PMID: 24266710 Free PMC article.
-
Jacobsen EA, Doyle AD, Colbert DC, Zellner KR, Protheroe CA, LeSuer WE, Lee NA, Lee JJ. Jacobsen EA, et al. Allergy. 2015 Sep;70(9):1148-59. doi: 10.1111/all.12655. Epub 2015 Jun 14. Allergy. 2015. PMID: 26009788 Free PMC article.
-
Jacobsen EA, Zellner KR, Colbert D, Lee NA, Lee JJ. Jacobsen EA, et al. J Immunol. 2011 Dec 1;187(11):6059-68. doi: 10.4049/jimmunol.1102299. Epub 2011 Nov 2. J Immunol. 2011. PMID: 22048766 Free PMC article.
-
Lee NA, Gelfand EW, Lee JJ. Lee NA, et al. J Allergy Clin Immunol. 2001 Jun;107(6):945-57. doi: 10.1067/mai.2001.116002. J Allergy Clin Immunol. 2001. PMID: 11398070 Review.
-
Potential Mechanisms of T Cell-Mediated and Eosinophil-Independent Bronchial Hyperresponsiveness.
Saeki M, Nishimura T, Kitamura N, Hiroi T, Mori A, Kaminuma O. Saeki M, et al. Int J Mol Sci. 2019 Jun 18;20(12):2980. doi: 10.3390/ijms20122980. Int J Mol Sci. 2019. PMID: 31216735 Free PMC article. Review.
Cited by
-
Revisiting the NIH Taskforce on the Research needs of Eosinophil-Associated Diseases (RE-TREAD).
Khoury P, Akuthota P, Ackerman SJ, Arron JR, Bochner BS, Collins MH, Kahn JE, Fulkerson PC, Gleich GJ, Gopal-Srivastava R, Jacobsen EA, Leiferman KM, Francesca LS, Mathur SK, Minnicozzi M, Prussin C, Rothenberg ME, Roufosse F, Sable K, Simon D, Simon HU, Spencer LA, Steinfeld J, Wardlaw AJ, Wechsler ME, Weller PF, Klion AD. Khoury P, et al. J Leukoc Biol. 2018 Jul;104(1):69-83. doi: 10.1002/JLB.5MR0118-028R. Epub 2018 Apr 19. J Leukoc Biol. 2018. PMID: 29672914 Free PMC article. Review.
-
Secreted PLA2 group X orchestrates innate and adaptive immune responses to inhaled allergen.
Nolin JD, Lai Y, Ogden HL, Manicone AM, Murphy RC, An D, Frevert CW, Ghomashchi F, Naika GS, Gelb MH, Gauvreau GM, Piliponsky AM, Altemeier WA, Hallstrand TS. Nolin JD, et al. JCI Insight. 2017 Nov 2;2(21):e94929. doi: 10.1172/jci.insight.94929. JCI Insight. 2017. PMID: 29093264 Free PMC article.
-
Eosinophils in Eosinophilic Esophagitis: The Road to Fibrostenosis is Paved With Good Intentions.
Doyle AD, Masuda MY, Kita H, Wright BL. Doyle AD, et al. Front Immunol. 2020 Dec 1;11:603295. doi: 10.3389/fimmu.2020.603295. eCollection 2020. Front Immunol. 2020. PMID: 33335531 Free PMC article. Review.
-
Eosinophils in Helminth Infection: Defenders and Dupes.
Huang L, Appleton JA. Huang L, et al. Trends Parasitol. 2016 Oct;32(10):798-807. doi: 10.1016/j.pt.2016.05.004. Epub 2016 Jun 1. Trends Parasitol. 2016. PMID: 27262918 Free PMC article. Review.
-
Stokes K, LaMarche NM, Islam N, Wood A, Huang W, August A. Stokes K, et al. J Immunol. 2015 Mar 15;194(6):2477-81. doi: 10.4049/jimmunol.1402096. Epub 2015 Feb 13. J Immunol. 2015. PMID: 25681342 Free PMC article.
References
-
- Kumar RK, Herbert C, Foster PS. The "classical" ovalbumin challenge model of asthma in mice. Curr Drug Targets. 2008;9:485–494. - PubMed
-
- Martin TR, Gerard NP, Galli SJ, Drazen JM. Pulmonary responses to bronchoconstrictor agonists in the mouse. J Appl Physiol. 1988;64:2318–2323. - PubMed
-
- Molfino NA, Gossage D, Kolbeck R, Parker JM, Geba GP. Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor. Clin Exp Allergy. 2012;42:712–737. - PubMed
-
- Kung TT, Stelts DM, Zurcher JA, Adams GK, Egan RW, Kreutner W, et al. Involvement of IL-5 in a murine model of allergic pulmonary inflammation - prophylactic and therapeutic effect of an anti-IL-5 antibody. Am J Respir Cell Mol Biol. 1995;13:360–365. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources